November 09, 2020 – Vancouver, BC: Quark Venture LP (Quark) and GF Securities are pleased to announce the successful listing of portfolio company, SQZ Biotechnologies (NYSE: SQZ) (“SQZ”) on the… Read More
-NL-201 IND submission anticipated by year end 2020– –Clinical Trial Notification application submitted in Australia– -Ended 3rd quarter with $201.2 million in cash and cash equivalents– SEATTLE, Nov. 09, 2020… Read More
Vancouver, BC – November 5, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and… Read More
Vancouver, B.C. – German biotech firm CureVac has just announced positive preliminary results (https://bit.ly/34TK6Qn) from clinical studies on its COVID-19 vaccine, and it comes with a strong Canadian connection. Vancouver-based… Read More
– Intranasal administration of NL-CVX1 protects hamsters from lethal SARS-CoV-2 infection – – Designed to resist viral mutational escape by mimicking the natural target of the spike protein – SEATTLE, Nov. 05, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods… Read More
